Neurology

MS is a chronic inflammatory disease of the CNS, the pathogenesis associated with miRNAs. miRNAs also serve as effective therapeutic targets in MS patients. Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS). MicroRNAs (miRNAs) are complex endogenous biomolecules that function as gene super-regulators. This review was published in...

Patients with MS demonstrate an accumulation of disabilities, which can be delayed by applying disease-modifying therapies. Multiple sclerosis (MS) patients acquire disability via progression independent of relapse activity (PIRA) or relapse-associated worsening (RAW). This study was published in the journal BRAIN, and discusses the contribution of MS relapses to the worsening of disability through the...

A recent clinical trial indicates that self-acupressure is an effective non-pharmaceutical treatment for reducing fatigue in multiple sclerosis patients. Multiple Sclerosis (MS) is a neurological illness that causes inflammation, neurological impairment, and neurodegeneration in the central nervous system. The disorder may potentially cause irreparable damage to the nerves. One of the major symptoms of MS...

Socioeconomic disadvantage may be a potential risk factor for poor clinical outcomes in patients with multiple sclerosis (MS). A retrospective analysis was conducted to assess this association and open the discussion for possible solutions. Patients with multiple sclerosis (MS) who are at a socioeconomic disadvantage may bear a high burden of disease and worse outcomes....

The prevalence of multiple sclerosis (MS) in minority populations is not well documented or understood. A retrospective cohort analysis evaluated the prevalence of MS with data gathered from a Florida database and provided insight into the prevalence and care of MS. Nearly one million people live with multiple sclerosis (MS) in the United States. However,...

The number of studies on women’s health and multiple sclerosis (MS) has increased over recent years; however, knowledge gaps are still apparent. A recent scoping review addressed the available data. Women with multiple sclerosis (MS) face unique health challenges related to pregnancy, contraception, and menopause. Despite these challenges, limited studies are available that highlight these...

Limited data on the course, progression, and treatment of MS in African Americans from clinical trials is available. A recent study summarized the current data and calls for advancing the care of multiple sclerosis in African Americans. Few studies have outlined the effects of a various factors, including genetics, environmental factors, and social determinants of...

The prevalence of multiple sclerosis (MS) varies according to race and ethnicity, as reported in a study based in Southern California. The results of this study underscore the need for appropriate treatment of African Americans with MS about whom previous widespread beliefs have skewed the perceived prevalence of MS. According to a study published in...

Certain racial and ethnic groups, such as African Americans and Hispanics, may be disproportionately affected by multiple sclerosis compared to Whites. Understanding the differences in potential risk factors could aid clinicians in formulating the right treatment plan. Certain racial and ethnic groups may bear an unequal burden of disease in regard to multiple sclerosis (MS)....